Chemotaktische Aktivität von Fibroblasten bei Mukopolysaccharidosen.

Translated title of the contribution: Chemotactic activity of fibroblasts in mucopolysaccharidoses

A. Albini, B. Pontz, H. Mensing, M. Cantz, P. K. Müller

Research output: Contribution to journalArticle

Abstract

Certain clinical symptoms such as hernias or joint contracture in patients with mucopolysaccharidoses (MPS) cannot be explained as direct consequences of the disturbed glycosaminoglycan metabolism. They may be related to secondary changes of connective tissue components. The glycoprotein fibronectin is a constituent of connective tissue with a high affinity to polyanions such as heparan sulfate or heparin. Fibronectin in addition is a potent stimulus for fibroblasts to migrate chemotactically. We studied this cell property in MPS fibroblasts. The chemotactic activity of all MPS types was diminished. MPS II fibroblasts were chemotactically inactive. When the cells were corrected for the lacking enzyme by adding conditioned medium from control fibroblasts, the chemotactic migration increased except for MPS type II cells. The known enzyme defect in the degradation process of glycosaminoglycans in MPS results in lysosomal storage of degradation products and in addition causes changes of other cell properties.

Original languageGerman
Pages (from-to)263-267
Number of pages5
JournalPadiatrie und Padologie
Volume18
Issue number3
Publication statusPublished - 1983

Fingerprint

Mucopolysaccharidoses
Fibroblasts
Mucopolysaccharidosis II
Glycosaminoglycans
Fibronectins
Connective Tissue
Mucopolysaccharidosis I
Heparitin Sulfate
Contracture
Enzymes
Hernia
Conditioned Culture Medium
Heparin
Glycoproteins
Joints

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Albini, A., Pontz, B., Mensing, H., Cantz, M., & Müller, P. K. (1983). Chemotaktische Aktivität von Fibroblasten bei Mukopolysaccharidosen. Padiatrie und Padologie, 18(3), 263-267.

Chemotaktische Aktivität von Fibroblasten bei Mukopolysaccharidosen. / Albini, A.; Pontz, B.; Mensing, H.; Cantz, M.; Müller, P. K.

In: Padiatrie und Padologie, Vol. 18, No. 3, 1983, p. 263-267.

Research output: Contribution to journalArticle

Albini, A, Pontz, B, Mensing, H, Cantz, M & Müller, PK 1983, 'Chemotaktische Aktivität von Fibroblasten bei Mukopolysaccharidosen.', Padiatrie und Padologie, vol. 18, no. 3, pp. 263-267.
Albini, A. ; Pontz, B. ; Mensing, H. ; Cantz, M. ; Müller, P. K. / Chemotaktische Aktivität von Fibroblasten bei Mukopolysaccharidosen. In: Padiatrie und Padologie. 1983 ; Vol. 18, No. 3. pp. 263-267.
@article{ccb6407ed7a246e1871fc34e2d566b4c,
title = "Chemotaktische Aktivit{\"a}t von Fibroblasten bei Mukopolysaccharidosen.",
abstract = "Certain clinical symptoms such as hernias or joint contracture in patients with mucopolysaccharidoses (MPS) cannot be explained as direct consequences of the disturbed glycosaminoglycan metabolism. They may be related to secondary changes of connective tissue components. The glycoprotein fibronectin is a constituent of connective tissue with a high affinity to polyanions such as heparan sulfate or heparin. Fibronectin in addition is a potent stimulus for fibroblasts to migrate chemotactically. We studied this cell property in MPS fibroblasts. The chemotactic activity of all MPS types was diminished. MPS II fibroblasts were chemotactically inactive. When the cells were corrected for the lacking enzyme by adding conditioned medium from control fibroblasts, the chemotactic migration increased except for MPS type II cells. The known enzyme defect in the degradation process of glycosaminoglycans in MPS results in lysosomal storage of degradation products and in addition causes changes of other cell properties.",
author = "A. Albini and B. Pontz and H. Mensing and M. Cantz and M{\"u}ller, {P. K.}",
year = "1983",
language = "Tedesco",
volume = "18",
pages = "263--267",
journal = "Padiatrie und Padologie",
issn = "0030-9338",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Chemotaktische Aktivität von Fibroblasten bei Mukopolysaccharidosen.

AU - Albini, A.

AU - Pontz, B.

AU - Mensing, H.

AU - Cantz, M.

AU - Müller, P. K.

PY - 1983

Y1 - 1983

N2 - Certain clinical symptoms such as hernias or joint contracture in patients with mucopolysaccharidoses (MPS) cannot be explained as direct consequences of the disturbed glycosaminoglycan metabolism. They may be related to secondary changes of connective tissue components. The glycoprotein fibronectin is a constituent of connective tissue with a high affinity to polyanions such as heparan sulfate or heparin. Fibronectin in addition is a potent stimulus for fibroblasts to migrate chemotactically. We studied this cell property in MPS fibroblasts. The chemotactic activity of all MPS types was diminished. MPS II fibroblasts were chemotactically inactive. When the cells were corrected for the lacking enzyme by adding conditioned medium from control fibroblasts, the chemotactic migration increased except for MPS type II cells. The known enzyme defect in the degradation process of glycosaminoglycans in MPS results in lysosomal storage of degradation products and in addition causes changes of other cell properties.

AB - Certain clinical symptoms such as hernias or joint contracture in patients with mucopolysaccharidoses (MPS) cannot be explained as direct consequences of the disturbed glycosaminoglycan metabolism. They may be related to secondary changes of connective tissue components. The glycoprotein fibronectin is a constituent of connective tissue with a high affinity to polyanions such as heparan sulfate or heparin. Fibronectin in addition is a potent stimulus for fibroblasts to migrate chemotactically. We studied this cell property in MPS fibroblasts. The chemotactic activity of all MPS types was diminished. MPS II fibroblasts were chemotactically inactive. When the cells were corrected for the lacking enzyme by adding conditioned medium from control fibroblasts, the chemotactic migration increased except for MPS type II cells. The known enzyme defect in the degradation process of glycosaminoglycans in MPS results in lysosomal storage of degradation products and in addition causes changes of other cell properties.

UR - http://www.scopus.com/inward/record.url?scp=0020676073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020676073&partnerID=8YFLogxK

M3 - Articolo

C2 - 6412199

AN - SCOPUS:0020676073

VL - 18

SP - 263

EP - 267

JO - Padiatrie und Padologie

JF - Padiatrie und Padologie

SN - 0030-9338

IS - 3

ER -